Get early access! Join the Twelve Data AI Assistant waitlist now.

TLX

ASX
18.93000 AUD
0.17
0.91%
Last update Aug 26, 3:59 PM AEST
Pre-market
Day range
18.18500
19.030001
Previous close
18.76000
Open
18.32000
Access this stock data via API
Subscribe
Telix Pharmaceuticals Limited
18.93
0.17
0.91%

Overview

Description

Telix Pharmaceuticals Limited is a biotechnology company that specializes in the development and commercialization of targeted radiopharmaceuticals, primarily for the diagnosis and treatment of cancer. The company focuses on harnessing the power of molecularly targeted radiation therapy, aiming to deliver precision medicine solutions that can improve outcomes for patients with serious oncological and rare diseases. Telix Pharmaceuticals Limited's innovative pipeline features next-generation therapeutic candidates and utilizes proprietary biologics and protein engineering platforms to advance novel treatments. Its activities play a significant role in the healthcare sector, particularly within oncology, by addressing unmet medical needs and contributing to advancements in both diagnostics and therapeutics. As a recognized innovator in the field of radiopharmaceuticals, Telix Pharmaceuticals Limited holds a prominent position in the evolving landscape of cancer treatment and medical imaging.

About

CEO
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA
Employees
415
Address
55 Flemington Road
Level 4
North Melbourne, 3051, VIC
Australia
Phone
61 3 9093 3855
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
Australia
MIC code
XASX
Pre-market

Exchange is currently open for pre-market.
Main market opens in 1 hour 16 minutes

08:43
00:00
10:00
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 10:00
Main market
10:00 - 16:00
Post-market
16:00 - 16:12
All times are displayed in the Australia/Sydney timezone (AEST, UTC+10:00).